Urologische Klinik


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Piwi-like 1 and-2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients (2018) Eckstein M, Jung R, Weigelt K, Sikic D, Stoehr R, Geppert CI, Agaimy A, et al. Journal article Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival (2018) Greither T, Fischer K, Theil G, Marcou M, Holzhausen HJ, Weigelt K, Serrero G, et al. Journal article Elevated HERV-K Expression in Soft Tissue Sarcoma Is Associated with Worsened Relapse-Free Survival (2018) Giebler M, Staege MS, Blauschmidt S, Ohm LI, Kraus M, Wuerl P, Taubert H, Greither T Journal article Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL (2018) Boegemann M, Bedke J, Schostak M, Welslau M, Hering-Schubert C, Wolf T, Schleicher J, et al. Conference contribution Follow-up of bladder cancer. The right examinations at the right time (2018) Olbert P, Goebell P, Hegele A Journal article Geriatric Urology (2018) Kahlmeyer A, Wullich B, Wiedemann A Journal article Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars series (2018) Black PC, Goebell P, Kamat AM, Nawroth R, Schmitz-Draeger BJ Journal article, Editorial Evolution of PD-1 and PD-L1 Gene and Protein Expression in Primary Tumors and Corresponding Liver Metastases of Metastatic Bladder Cancer (2018) Eckstein M, Sikic D, Strissel P, Erlmeier F Journal article Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer (2018) Schmidkonz C, Cordes M, Beck M, Goetz TI, Schmidt D, Prante O, Bäuerle T, et al. Journal article ATLAS: a phase 2, open-label study of rucaparib in patients with locally advanced (unresectable) or metastatic urothelial carcinoma (2018) Feyerabend S, Boegemann M, Goebell P, Stoeckle M, Nepert D, Wride K, Thomas D, et al. Conference contribution